CClinicalTrials.gg
CompletedNCT01704456COMFORTUpdated Mar 10, 2020Results posted

Integrated Mindfulness-based Cognitive Behaviour Therapy Versus Cognitive Behaviour Therapy for Provoked Vestibulodynia

An interventional study of Mindfulness-based Cognitive Therapy and Cognitive Behavioural Therapy in Provoked Vestibulodynia, sponsored by University of British Columbia. Completed at 2 sites in Canada. Open to female participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2020-03-10.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
19 Years and older
Sex
Female
01

Study summary

This randomized trial, nicknamed the COMFORT (Cognitive therapy or Mindfulness FOR Treatment of pvd) study, will compare the effects of an 8-session group Mindfulness-based Cognitive Therapy (MBCT) to an 8-session group Cognitive Behavioural Therapy (CBT) for women with provoked vestibulodynia (PVD). Women with PVD will be randomly assigned to attend either eight sessions of group MBCT or CBT. Each session is 2.25 hours long and spaced 1 week apart. The purpose of this study is to determine whether the 8-session MBCT intervention for PVD is no worse than an 8-session CBT intervention for decreasing women's pain intensity, sexual distress, catastrophizing and hypervigilance towards pain.

Read the detailed description

PURPOSE:

The purpose of this study is to determine whether an 8-session MBCT intervention for PVD is no worse than an 8-session CBT intervention for improving women's pain intensity and reducing their sexual distress, catastrophizing and hypervigilance towards pain. The investigators will also examine whether pain improvements at follow-up are mediated by changes in self-compassion and mindfulness (in the MBCT arm only) and moderated by pre-treatment credibility, personality, and anxiety sensitivity.

HYPOTHESES:

  1. At follow-up (4 weeks, 6 months and 12 months post-treatment), women in the MBCT arm will experience a greater decline (vs. pre-treatment) in vestibular pain intensity compared to women in the CBT arm.
  2. At follow-up (4 weeks, 6 months and 12 months post-treatment), women in the MBCT arm will experience a greater decline (vs. pre-treatment) in sex-related distress, pain catastrophizing, hypervigilance, and self-reported pain during intercourse/other penetrative sex compared to women in the CBT arm.
  3. The investigators hypothesize that improvements in pain intensity during vestibular touch will be mediated by changes in self-compassion and mindfulness in the MBCT arm only at 6 and 12 months follow-up.
  4. The investigators hypothesize that pre-treatment credibility, personality, and anxiety sensitivity will significantly moderate improvements in pain intensity during vestibular touch at 6 and 12 months follow-up.
  5. The investigators hypothesize improvements in both arms on the "Patient Global Impression of Change Scale" and significantly greater improvements in the MBCT arm relative to the CBT arm at follow-up (4 weeks, 6 months and 12 months post-treatment).
02

Conditions studied

  • Provoked Vestibulodynia

Keywords

  • provoked vestibulodynia
  • dyspareunia
  • vulvodynia
  • mindfulness
  • cognitive behavioural therapy
03

In context

Vulvodynia

106 studies on the registry are indexed under Vulvodynia; 21 are open to participants now.

This study's enrollment of 130 is above the median of 44 across 79 interventional studies indexed under Vulvodynia.

Browse Vulvodynia studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of provoked vestibulodynia (PVD)
  • 19 years of age or older
  • premenopausal
  • fluent in English
  • during the study, women must agree not to change any medications they are taking for PVD.

Exclusion criteria

Exclusion Criteria:

  • unprovoked vulvar pain, other pathology causing pain with penetration, or chronic pelvic pain
  • being uncomfortable and unwilling to participate in a group setting.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
130 participants (actual)

Study arms

  • Experimental
    Mindfulness-based cognitive therapy (MBCT)

    Women in the MBCT Group Treatment arm will receive the treatment in small group format (8-9 women). Each session will be 2.25 hours in duration and there will be eight, weekly sessions over the course of 2 months. Session content includes education about chronic pain, PVD, stress and sexual response, mindfulness practices, and cognitive techniques to notice thought patterns that contribute to increased pain.

    Behavioral: Mindfulness-based Cognitive Therapy

  • Experimental
    Cognitive Behavioural Therapy (CBT)

    Women in the CBT Group Treatment arm will receive the treatment in small group format (8-9 women). Each session will be 2.25 hrs in duration and there will be eight, weekly sessions over the course of 2 months. Session content includes education about chronic pain, PVD, stress and sexual response, behavioural techniques such as progressive muscle relaxation, cognitive techniques to challenge unhealthy thinking patterns, and communication skills training.

    Behavioral: Cognitive Behavioural Therapy

Interventions

  • BehavioralMindfulness-based Cognitive Therapy

    The MBCT intervention will be administered in small group format (8-9 women). Each session will be 2.25 hours in duration and there will be eight, weekly sessions over the course of 2 months. Session content includes education about chronic pain, PVD, stress and sexual response, mindfulness practices, and cognitive techniques to notice thought patterns that contribute to increased pain.

    Also known as: MBCT

  • BehavioralCognitive Behavioural Therapy

    The CBT intervention will be administered to women in small group format (8-9 women). Each session will be 2.25-hrs in duration and there will be eight, weekly sessions over the course of 2 months. Session content includes education about chronic pain, PVD, stress and sexual response, behavioural techniques such as progressive muscle relaxation, cognitive techniques to challenge unhealthy thinking patterns, and communication skills training.

    Also known as: CBT

06

What researchers measure

Primary outcomes

  1. Change in Vulvslgesiometer Pain Rating From Baseline to One Month Post-treatment to 6 Months Post-treatment

    The investigators have selected pain intensity during a controlled examination as the primary endpoint in this study. Specifically, pain intensity at the vulvar vestibule will be assessed using a vulvalgesiometer. The vulvalgesiometer is an instrument that provides a measure of pain/sensitivity that can be standardized across time points. The vulvalgesiometer is calibrated to exert a fixed amount of pressure. In this study, 30 grams of pressure at the 1, 3, 4, 6, 8, 9, and 11 o'clock positions (randomly) around the vestibule will be applied using the vulvalgestiometer. Women will also report their pain at each site using a numeric rating scale from 0 (no pain) to 10 (worst pain ever).

    Time frame: Pre-treatment, one month post-treatment and 6 months post-treatment.

Secondary outcomes

  1. Self-reported Pain During Penetration

    The investigators will measure self-report of pain during attempted or completed intercourse (or dildo entry for non-heterosexual women). Numeric Rating Scale that asked participants to rate the "intensity of pain during vaginal penetration attempts with sexual intercourse or penetration over the past 4 weeks" This question was rated on a 0 to 10 scale from no pain (0) to worst possible pain (10).

    Time frame: Pre-treatment,one month post-treatment, and 6 months follow-up.

  2. Sexual Function

    The investigators will examine women's self-reported sexual function by administering the Female Sexual Function Index (FSFI). The Female Sexual Function Index (FSFI) is a 19-item self-report questionnaire which assesses sexual function in women. It covers six sexual domains: lubrication, arousal, desire, pain, orgasm and satisfaction. Scores range from 7.2 - 36 where increase in sexual dysfunction is represented by lower scores. Subscales: Desire- 2, 3 \[Subscale scores Range: 1.2 - 6\] Arousal- 5,6,7,8 \[Subscale Scores Range: 1.2 - 6\] Lubrication- 9,10,11,12 \[Subscale Scores Range: 1.2 - 6\] Orgasm- 13, 14, 15 \[Subscale Scores Range: 1.2 - 6\] Satisfaction- 1, 16, 17 \[Subscale Scores Range: 1.2 - 6\] Pain- 18, 19, 20 \[Subscale Scores Range: 1.2 - 6\] Extra item: (4) have you been sexually active in past 4 weeks? (yes/no) \[Scores Range 0 (no) - 1 (yes)\] Note: Ranges applicable only if question 4 was answered "yes".

    Time frame: Pre-treatment, one month post-treatment, and 6 months post-treatment.

  3. Sexual Distress

    The investigators will examine women's self-reported sexual distress by administering the Female Sexual Distress Scale-Revised. This is a 12-item self-report questionnaire assessing for sexuality related personal distress. Scores on the scale range from 0 - 48, where higher scores represent higher levels of distress.

    Time frame: Pre-treatment, one month post-treatment, and 6 months post-treatment.

  4. Pain Catastrophizing

    The investigators will examine women's self-reported pain catastrophizing by administering the Pain Catastrophizing Scale. The Pain Catastrophizing Scale (PCS) is a self-report questionnaire that asks participants to think about past painful experiences, or a specific experience of pain, and to indicate the degree to which they have any of the presented thoughts or feelings when they are experiencing pain. Each one of the 13-items is rated on a Likert scale from 0 (not at all) to 4 (all the time), where a higher total score indicates higher pain catastrophizing. Subscales: Rumination- (4 items) 8, 9, 10, and 11 \[Scores Range: 0 - 16\] Magnification- (3 items) 6, 7, and 13 \[Scores Range: 0 - 12\] Helplessness- (6 items) 1, 2, 3, 4, 5, and 12 \[Scores Range: 0 - 24\] Sum of all items \[Overall Range: 0 - 52\]

    Time frame: Pre-treatment, one month post-treatment, and 6 months post-treatment..

  5. Pain Hypervigilance

    The investigators will examine women's self-reported hypervigilance about pain by administering the Pain Vigilance and Awareness Questionnaire. The Pain Vigilance and Awareness Questionnaire (PVAQ) is a 16 item self-report measure to assess the awareness, vigilance, preoccupation and observation of pain. Sum total score \[Scores Range: 0 - 80\].

    Time frame: Pre-treatment, one month post-treatment, and 6 months post treatment.

  6. Chronic Pain Acceptance, Activities Engagement

    The investigators will examine women's self-reported pain acceptance, activities engagement, by administering the CPAQ chronic pain acceptance questionnaire. The Chronic Pain Acceptance Questionnaire (CPAQ) measures the degree of acceptance of pain by chronic pain patients. It consists of 20 items measuring two domains, Activities Engagement and Pain Willingness. Total score range is from 0 - 120, with higher scores indicating higher levels of pain acceptance. Subscales: Activities engagement (11 items)- Q 1, 2, 3, 5, 6, 8, 9, 10, 12, 15, 19 \[Scores Range: 0 - 66\] Pain willingness (9 items)- Q 4, 7, 11, 13, 14, 16, 17, 18, 20 \[Scores Range: 0 - 54\]

    Time frame: Pre-treatment, one month post-treatment, and 6 months post-treatment.

  7. Chronic Pain Acceptance, CPAQ Pain Willingness

    The investigators will examine women's self-reported pain acceptance, activities engagement, by administering the CPAQ chronic pain acceptance questionnaire. The Chronic Pain Acceptance Questionnaire (CPAQ) measures the degree of acceptance of pain by chronic pain patients. It consists of 20 items measuring two domains: Activities Engagement and Pain Willingness. Total score range is from 0 - 120, with higher scores indicating higher levels of pain acceptance. Subscales: Activities engagement (11 items)- Q 1, 2, 3, 5, 6, 8, 9, 10, 12, 15, 19 \[Scores Range: 0 - 66\] Pain willingness (9 items)- Q 4, 7, 11, 13, 14, 16, 17, 18, 20 \[Scores Range: 0 - 54\]

    Time frame: Pre-treatment, one month post-treatment, and 6 months post treatment.

07

Results

Posted Mar 10, 2020

Participant flow

Participant flow — Overall Study
MilestoneMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Started6763
Completed5949
Not completed814
Withdrew: Lost to follow-up814

Outcome measures

PrimaryChange in Vulvslgesiometer Pain Rating From Baseline to One Month Post-treatment to 6 Months Post-treatment

The investigators have selected pain intensity during a controlled examination as the primary endpoint in this study. Specifically, pain intensity at the vulvar vestibule will be assessed using a vulvalgesiometer. The vulvalgesiometer is an instrument that provides a measure of pain/sensitivity that can be standardized across time points. The vulvalgesiometer is calibrated to exert a fixed amount of pressure. In this study, 30 grams of pressure at the 1, 3, 4, 6, 8, 9, and 11 o'clock positions (randomly) around the vestibule will be applied using the vulvalgestiometer. Women will also report their pain at each site using a numeric rating scale from 0 (no pain) to 10 (worst pain ever).

Time frame:
Pre-treatment, one month post-treatment and 6 months post-treatment.
Reported as:
Mean · score on a scale
Change in Vulvslgesiometer Pain Rating From Baseline to One Month Post-treatment to 6 Months Post-treatment
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
pre-treatment6.66 ± 2.176.62 ± 2.19
one month post-treatment3.21 ± 1.963.60 ± 2.14
6 months follow up2.92 ± 2.312.86 ± 1.89
SecondarySelf-reported Pain During Penetration

The investigators will measure self-report of pain during attempted or completed intercourse (or dildo entry for non-heterosexual women). Numeric Rating Scale that asked participants to rate the "intensity of pain during vaginal penetration attempts with sexual intercourse or penetration over the past 4 weeks" This question was rated on a 0 to 10 scale from no pain (0) to worst possible pain (10).

Time frame:
Pre-treatment,one month post-treatment, and 6 months follow-up.
Reported as:
Mean · score on a scale
Self-reported Pain During Penetration
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Pre-treatment6.69 ± 1.915.86 ± 2.13
One Month Post-Treatment4.34 ± 2.224.65 ± 2.21
6 months follow up3.39 ± 1.894.03 ± 2.11
SecondarySexual Function

The investigators will examine women's self-reported sexual function by administering the Female Sexual Function Index (FSFI). The Female Sexual Function Index (FSFI) is a 19-item self-report questionnaire which assesses sexual function in women. It covers six sexual domains: lubrication, arousal, desire, pain, orgasm and satisfaction. Scores range from 7.2 - 36 where increase in sexual dysfunction is represented by lower scores. Subscales: Desire- 2, 3 \[Subscale scores Range: 1.2 - 6\] Arousal- 5,6,7,8 \[Subscale Scores Range: 1.2 - 6\] Lubrication- 9,10,11,12 \[Subscale Scores Range: 1.2 - 6\] Orgasm- 13, 14, 15 \[Subscale Scores Range: 1.2 - 6\] Satisfaction- 1, 16, 17 \[Subscale Scores Range: 1.2 - 6\] Pain- 18, 19, 20 \[Subscale Scores Range: 1.2 - 6\] Extra item: (4) have you been sexually active in past 4 weeks? (yes/no) \[Scores Range 0 (no) - 1 (yes)\] Note: Ranges applicable only if question 4 was answered "yes".

Time frame:
Pre-treatment, one month post-treatment, and 6 months post-treatment.
Reported as:
Mean · score on a scale
Sexual Function
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Pre-Treatment19.57 ± 6.2921.18 ± 6.10
One Month Post-Treatment21.79 ± 6.8323.41 ± 5.72
6 months follow up24.75 ± 5.6223.20 ± 5.45
SecondarySexual Distress

The investigators will examine women's self-reported sexual distress by administering the Female Sexual Distress Scale-Revised. This is a 12-item self-report questionnaire assessing for sexuality related personal distress. Scores on the scale range from 0 - 48, where higher scores represent higher levels of distress.

Time frame:
Pre-treatment, one month post-treatment, and 6 months post-treatment.
Reported as:
Mean · score on a scale
Sexual Distress
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Pre-Treatment34.28 ± 11.1835.68 ± 10.43
One Month Post-Treatment26.60 ± 13.3524.93 ± 91.31
6 months follow up22.81 ± 12.9823.77 ± 9.61
SecondaryPain Catastrophizing

The investigators will examine women's self-reported pain catastrophizing by administering the Pain Catastrophizing Scale. The Pain Catastrophizing Scale (PCS) is a self-report questionnaire that asks participants to think about past painful experiences, or a specific experience of pain, and to indicate the degree to which they have any of the presented thoughts or feelings when they are experiencing pain. Each one of the 13-items is rated on a Likert scale from 0 (not at all) to 4 (all the time), where a higher total score indicates higher pain catastrophizing. Subscales: Rumination- (4 items) 8, 9, 10, and 11 \[Scores Range: 0 - 16\] Magnification- (3 items) 6, 7, and 13 \[Scores Range: 0 - 12\] Helplessness- (6 items) 1, 2, 3, 4, 5, and 12 \[Scores Range: 0 - 24\] Sum of all items \[Overall Range: 0 - 52\]

Time frame:
Pre-treatment, one month post-treatment, and 6 months post-treatment..
Reported as:
Mean · score on a scale
Pain Catastrophizing
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Pre-Treatment26.92 ± 12.8625.62 ± 11.97
One Month Post-Treatment15.64 ± 12.5412.57 ± 8.13
6 months follow up11.55 ± 9.9110.83 ± 7.66
SecondaryPain Hypervigilance

The investigators will examine women's self-reported hypervigilance about pain by administering the Pain Vigilance and Awareness Questionnaire. The Pain Vigilance and Awareness Questionnaire (PVAQ) is a 16 item self-report measure to assess the awareness, vigilance, preoccupation and observation of pain. Sum total score \[Scores Range: 0 - 80\].

Time frame:
Pre-treatment, one month post-treatment, and 6 months post treatment.
Reported as:
Mean · score on a scale
Pain Hypervigilance
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Pre-Treatment43.24 ± 14.6742.46 ± 12.12
One Month Post-Treatment39.74 ± 13.7240.32 ± 14.19
6 months follow up38.50 ± 13.8838.76 ± 14.47
SecondaryChronic Pain Acceptance, Activities Engagement

The investigators will examine women's self-reported pain acceptance, activities engagement, by administering the CPAQ chronic pain acceptance questionnaire. The Chronic Pain Acceptance Questionnaire (CPAQ) measures the degree of acceptance of pain by chronic pain patients. It consists of 20 items measuring two domains, Activities Engagement and Pain Willingness. Total score range is from 0 - 120, with higher scores indicating higher levels of pain acceptance. Subscales: Activities engagement (11 items)- Q 1, 2, 3, 5, 6, 8, 9, 10, 12, 15, 19 \[Scores Range: 0 - 66\] Pain willingness (9 items)- Q 4, 7, 11, 13, 14, 16, 17, 18, 20 \[Scores Range: 0 - 54\]

Time frame:
Pre-treatment, one month post-treatment, and 6 months post-treatment.
Reported as:
Mean · score on a scale
Chronic Pain Acceptance, Activities Engagement
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Pre-Treatment42.40 ± 10.9142.39 ± 10.14
One Month Post-Treatment47.97 ± 10.2646.63 ± 9.34
6 months follow up49.24 ± 9.2947.83 ± 8.70
SecondaryChronic Pain Acceptance, CPAQ Pain Willingness

The investigators will examine women's self-reported pain acceptance, activities engagement, by administering the CPAQ chronic pain acceptance questionnaire. The Chronic Pain Acceptance Questionnaire (CPAQ) measures the degree of acceptance of pain by chronic pain patients. It consists of 20 items measuring two domains: Activities Engagement and Pain Willingness. Total score range is from 0 - 120, with higher scores indicating higher levels of pain acceptance. Subscales: Activities engagement (11 items)- Q 1, 2, 3, 5, 6, 8, 9, 10, 12, 15, 19 \[Scores Range: 0 - 66\] Pain willingness (9 items)- Q 4, 7, 11, 13, 14, 16, 17, 18, 20 \[Scores Range: 0 - 54\]

Time frame:
Pre-treatment, one month post-treatment, and 6 months post treatment.
Reported as:
Mean · score on a scale
Chronic Pain Acceptance, CPAQ Pain Willingness
score on a scaleMindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)
Pre-Treatment23.99 ± 9.2922.91 ± 8.05
One Month Post-Treatment29.34 ± 10.0729.20 ± 8.42
6 months follow up33.72 ± 8.8031.29 ± 8.51

Adverse events

Collected over The entire duration of the study up to 6 months post treatment.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mindfulness-based Cognitive Therapy (MBCT)———
Cognitive Behavioural Therapy (CBT)———

Baseline characteristics

Participants comprised a total of 130 women diagnosed with PVD by a physician.

Age, Continuous
Age, Continuous(years)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
Mean33.72 ± 7.4831.24 ± 8.9932.35 ± 8.21
Sex: Female, Male
Sex: Female, Male(Participants)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
Female6763130
Male000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(participants)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
Euro-Canadian463884
South/East Asian101121
Other91221
Prefer Not To Answer224
Relationship status
Relationship status(Participants)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
Married / Common Law454186
Dating111324
Single11819
Did Not Disclose011
Length of relationship
Length of relationship(years)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
Mean7.77 ± 6.167.56 ± 6.797.67 ± 7.52
Satisfaction with relationship closeness (/10)
Satisfaction with relationship closeness (/10)(units on a scale)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
Mean7.26 ± 2.297.79 ± 1.997.52 ± 2.15
Education
Education(participants)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
High School123
Some College101727
University Degree312455
Post-Graduate171330
Prefer Not To Answer8715
Level of typical pain (/10)
Level of typical pain (/10)(units on a scale)Mindfulness-based Cognitive Therapy (MBCT)Cognitive Behavioural Therapy (CBT)Total
Mean6.04 ± 1.825.96 ± 2.116.00 ± 1.96

5 further baseline measures are reported on the registry.

08

Study locations

2 sites
  • British Columbia Centre for Sexual Medicine
    Vancouver, British Columbia V5Z 1M9, Canada
  • Department of Gynaecology
    Vancouver, British Columbia V5Z 1M9, Canada
09

References and documents

Publications

  • Brotto LA, Zdaniuk B, Rietchel L, Basson R, Bergeron S. Moderators of Improvement From Mindfulness-Based vs Traditional Cognitive Behavioral Therapy for the Treatment of Provoked Vestibulodynia. J Sex Med. 2020 Nov;17(11):2247-2259. doi: 10.1016/j.jsxm.2020.07.080. Epub 2020 Aug 22. PubMed 32843320 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01704456
Lead sponsor
University of British Columbia
Responsible party
Lori Brotto (Associate Professor, University of British Columbia) — Principal investigator
First posted
Oct 11, 2012
Start date
Oct 2012
Primary completion
Sep 2016
Completion
Sep 2017
Results posted
Mar 10, 2020
Last update
Mar 10, 2020

Study contacts

Lori A Brotto, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion